Status:
UNKNOWN
New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Decompensated Cirrhosis
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The MELD score is a predictive model of cirrhosis mortality used in France since 2007 to prioritize access to liver transplantation for patients enrolled in the national waiting list. The predictive v...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years old) newly registered on national waiting list with main diagnosis "cirrhosis"
- Patients enrolled on the national waiting list under the "national liver score" allocation scheme whether an expert component is considered or not
- Patients (or trusted person or family member or close relation if the patient is unable to express consent) who have been informed and signed their informed consent
- Patients affiliated to a health insurance scheme
Exclusion
- Patients enrolled with decompensated cirrhosis associated with hepatocellular carcinoma
- Patients on AVK (INR and therefore MELD and CLIF scores uninterpretable)
- Vulnerable population (person under guardianship or curatorship or deprived of liberty by a judicial decision)
- Pregnant and / or breastfeeding woman
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03820271
Start Date
October 1 2020
End Date
October 1 2023
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pr Duvoux
Créteil, France, 94000